-
ACTELION PHARMACEUTICALS LTD. et al v. NATCO PHARMA LIMITED et al DC
- 3:19-cv-12984
- D.N.J.
- Judge: Brian R. Martinotti +1
- Filed: 05/28/2019
- Closed: 11/26/2019
- Latest Docket Entry: 11/26/2019
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
183
Days in
Litigation
-
ACTELION PHARMACEUTICALS LTD. et al v. NATCO PHARMA LIMITED et al DC
- 3:19-cv-12984
- D.N.J.
- Judge: Brian R. Martinotti +1
- Filed: 05/28/2019
- Closed: 11/26/2019
- Latest Docket Entry: 11/26/2019
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
4 |
The dispersible tablet according to any one of the preceding claims comprising at least one acidifying agent and/or at least one flavouring agent and/or at least one sweetening agent.
|
Enforceable and Valid
Entry 16 |
6 |
The dispersible tablet according to any one of the preceding claims wherein compound I is in the monohydrate form.
|
Enforceable and Valid
Entry 16 |
7 |
The dispersible tablet according to any one of the preceding claims obtainable by using the method of direct compression.
|
Enforceable and Valid
Entry 16 |
8 |
A method for treating pulmonary arterial hypertension, comprising dispersing the dispersible tablet of claim 1 in aqueous media to form a suspension and administering the suspension to a patient in need thereof.
|
Enforceable and Valid
Entry 16 |
9 |
A process for the preparation of a dispersible tablet according to any one of claims 1 to 7, characterized in that the tablet is prepared by direct compression.
|
Enforceable and Valid
Entry 16 |